Evaluation of peptide-HLA binding by an enzyme-linked assay and its application to the detailed peptide motifs for HLA-DR9 (DRB1*0901)

Journal of Immunological Methods

Volumn 201, Issue 2, 1997, Pages 157-163

  Fujisao, Shoji ^a   Nishimura, Yasuharu ^a   Matsushita, Sho ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

binding assay; biotinylated peptide; ELISA; HLA DR9; peptide motif

Indexed keywords

HLA DR ANTIGEN; SYNTHETIC PEPTIDE;

ARTICLE; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HLA-DR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031018915     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(96)00234-7     Document Type: Article

References (21)

1. Buus, S., Sette, A., Colon, S.M., Jenis, D.M. and Grey, H.M. (1986) Isolation and characterization of antigen-Ia complexes involved in T cell recognition. Cell 47, 1071.
2. Demotz, S., Grey, H.M., Appella, E. and Sette, A. (1989) Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme. Nature 342, 682.
3. Fujisao, S., Matsushita, S., Nishi, T. and Nishimura, Y. (1996) Identification of HLA-DR9(DRB1 * 0901)-binding peptide motifs using a phage fUSE5 random peptide library. Hum. Immunol. 45, 131.
4. Hirayama, K., Nishimura, Y., Tsukamoto, K. and Sasazuki, T. (1986) Functional and molecular analysis of three distinct HLA-DR4 beta-chains responsible for the MLR between HLA-Dw4, Dw15, and DKT2. J. Immunol. 137, 924.
5. Jensen, P.E. (1991) Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J. Exp. Med. 174, 1111.
6. Kaiser, E., Colescott, R.L., Bossinger, C.D. and Cook, P.I. (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34, 595.
7. Kirschmann, D.A., Duffin, K.L., Smith, C.E., Welply, J.K., Howard, S.C., Schwartz, B.D. and Woulfe, S.L. (1995) Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J. Immunol. 155, 5655.
8. Koide, Y., Awashima, F., Yoshida, T.O., Takenouchi, T., Wakisaka, A., Moriuchi, J. and Aizawa, M. (1982) The role of three distinct Ia-like antigen molecules in human T cell proliferative responses: effect of monoclonal anti-Ia-like antibodies. J. Immunol. 129, 1061.
9. Matsuki, K., Juji, T., Tokunaga, K., Takamizawa, M., Maeda, H., Soda, M., Nomura, Y. and Segawa, M. (1990) HLA antigens in Japanese patients with myasthenia gravis. J. Clin. Invest. 86, 392.
10. Matsushita, S., Takahashi, K., Motoki, M., Komoriya, K., Ikagawa, S. and Nishimura, Y. (1994) Allele specificity of structural requirement for peptides bound to HLA- DRB1 * 0405 and -DRB1 * 0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J. Exp. Med. 180, 873.
11. Matsushita, S., Nishi, T., Oiso, M., Yamaoka, K., Yone, K., Kanai, T. and Nishimura, Y. (1996) HLA-DQ-binding peptide motifs. I. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int. Immunol. 8, 757.
12. McNicholl, J.M., Whitworth, W.C., Oftung, F., Fu, X., Shinnick, T., Jensen, P.E., Simon, M., Wohlhueter, R.M. and Karr, R.W. (1995) Structural requirements of peptide and MHC for DR(α,β1*0401)-restricted T cell antigen recognition. J. Immunol. 155, 1951.
13. Moudgil, K.D., Grewal, I.S., Jensen, P.E. and Sercarz, E.E. (1996) Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues. J. Exp. Med. 183, 535.
14. Murakami, S., Yokomizo, H., Matsushita, S., Ogawa, M. and Nishimura, Y. (1996) Binding of mutated Ras- or p53-derived peptides to HLA-DR molecules. Immunol. Lett. 49, 149.
15. O'Sullivan, D., Sidney, J., Appella, E., Walker, L., Phillips, L., Colon, S.M., Miles, C., Chesnut, R.W. and Sette, A. (1990) Characterization of the specificity of peptide binding to four DR haplotypes. J. Immunol. 145, 1799.
16. 57. Hum. Immunol., in press.
17. Sherman, M.A., Runnels, H.A., Moore, J.C., Stern, L.J. and Jensen, P.E. (1994) Membrane interactions influence the peptide binding behavior of DR1. J. Exp. Med. 179, 229.
18. Sherman, M.A., Weber, D.A. and Jensen, P.E. (1995) DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3, 197.
19. Spearman, C. (1904) Am. J. Psychiatry 15, 88.
20. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L. and Wiley, D.C. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215.
21. Tompkins, S.M., Rota, P.A., Moore, J.C. and Jensen, P.E. (1993) A europium fluoroimmunoassay for measuring binding of antigen to class II MHC glycoproteins. J. Immunol. Methods 163, 209.